Hollencrest Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3K Sell
176
-23
-12% -$1.51K ﹤0.01% 806
2026
Q1
$14.2K Hold
199
﹤0.01% 779
2025
Q4
$16.3K Hold
199
﹤0.01% 744
2025
Q3
$14.9K Hold
199
﹤0.01% 742
2025
Q2
$14.7K Sell
199
-2
-1% -$139 ﹤0.01% 711
2025
Q1
$16.2K Buy
201
+2
+1% +$172 ﹤0.01% 711
2024
Q4
$15.6K Hold
199
﹤0.01% 730
2024
Q3
$18.7K Hold
199
﹤0.01% 683
2024
Q2
$15.5K Sell
199
-11
-5% -$897 ﹤0.01% 697
2024
Q1
$19.1K Hold
210
﹤0.01% 642
2023
Q4
$16.2K Sell
210
-2,962
-93% -$207K ﹤0.01% 665
2023
Q3
$216K Buy
3,172
+20
+0.6% +$1.46K 0.02% 268
2023
Q2
$256K Buy
3,152
+119
+4% +$9.5K 0.03% 262
2023
Q1
$249K Buy
+3,033
New +$217K 0.03% 256

Other funds holding GEHC

Hollencrest Capital Management's GEHC Position: Q2 2026 in Review

Hollencrest Capital Management reduced its GE HealthCare (GEHC) stake by 12% in Q2 2026, selling an estimated $1.51K and leaving 176 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #806.

Hollencrest Capital Management first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $256K in Q2 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Hollencrest Capital Management held 176 shares of GE HealthCare worth $11.3K as of Q2 2026.
  • Hollencrest Capital Management sold 23 GE HealthCare shares in Q2 2026, an estimated $1.51K.
  • GE HealthCare made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q2 2026, its #806 holding.
  • Hollencrest Capital Management first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Hollencrest Capital Management's GE HealthCare position peaked at $256K in Q2 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Hollencrest Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.